Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115845) titled 'Mechanistic Study on Precise Immune Cell Phenotyping and Prognostic Prediction in Severe Infection' on Dec. 31, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The Second Affiliated Hospital of Wenzhou Medical University
Condition:
Sepsis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Group of sepsis:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=303415
Published by HT Digital Content Services with permission from Health Daily Digest....